BOSTON--(BUSINESS WIRE)--Feb. 23, 2006--Point Therapeutics, Inc. (NASDAQ:POTP) announced today the appointment of two additional advisors: Charles Dinarello, M.D., to the company’s Scientific Advisory Board and Antonio Grillo-Lopez, M.D. to the Clinical Advisory Board.
